Command Palette

Search for a command to run...

Sudarshan Pharma Industries Ltd.
29.11(-1.99%)
1W: -7.56%

Financials

Charts

YoY Net Sales
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Consistent revenue growth over the last four quarters indicates strong market demand for products.
  • Improved profit margins in the latest quarter reflect effective cost management strategies.
  • Increased investment in R&D suggests a focus on innovation and competitiveness in the manufacturing sector.
NEGATIVES
  • Rising raw material costs have impacted overall profitability, particularly in the latest quarter.
  • Inventory levels surged recently, indicating potential supply chain inefficiencies.
  • Declining operating cash flow suggests challenges in meeting short-term financial obligations.

Quarterly Results Data

FieldTrendJun 25
Revenue
-145.26
Expenses
-141.06
Operating Profit
-4.20
Other Income
-1.21
Interest
-5.96
Depreciation
-0.88
Profit Before Tax
-5.41
Tax
-1.45
Net Profit
-3.96
Eps in Rs
-0.16
Explore
Watchlists
Chat
Portfolio